SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-18-003506
Filing Date
2018-12-03
Accepted
2018-12-03 17:05:25
Documents
8
Period of Report
2018-11-27
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c92425_8k.htm 8-K 16620
2 c92425_ex99-1.htm EX-99.1 241394
3 GRAPHIC x1_c92425x37x1.jpg GRAPHIC 7056
4 GRAPHIC x1_c92425x37x2.jpg GRAPHIC 8673
5 GRAPHIC x1_c92425x38x1.jpg GRAPHIC 8048
6 GRAPHIC x1_c92425x38x2.jpg GRAPHIC 10376
7 c92425_ex99-2.htm EX-99.2 22256
8 GRAPHIC x1_c92425x43x1.jpg GRAPHIC 8809
  Complete submission text file 0000930413-18-003506.txt   341363
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 181214619
SIC: 8071 Services-Medical Laboratories